ECOLAB Third Quarter 2025 Supplemental 1 Cautionary statement Forward-Looking Information This communication contains forward looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements regarding macroeconomic conditions and our financial and business performance and prospects, including sales, earnings, special (gains) and charges, raw material costs, margins, pricing, currency translation, ...

Ecolab (ECL) reported $4.17 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 4.2%. EPS of $2.07 for the same period compares to $1.83 a year ago.The reported revenue represents a surprise of +1.05% over the Zacks Consensus Estimate of $4.12 billion. With the consensus EPS estimate being $2.06, the EPS surprise was +0.49%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street exp ...

Shares of Ecolab (NYSE:ECL) fell as much as 5.1% in the first half-hour of trading Tuesday after the cleaning, sanitation and water treatment company reported third-quarter results. The company posted adjusted earnings, which excludes special gains and charges, of $2.07 a share, matching analyst ...

Ecolab (ECL) came out with quarterly earnings of $2.07 per share, beating the Zacks Consensus Estimate of $2.06 per share. This compares to earnings of $1.83 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +0.49%. A quarter ago, it was expected that this cleaning, food-safety and pest-control services company would post earnings of $1.9 per share when it actually produced earnings of $1.89, delivering a surprise of -0.53%.Over ...

Financial Performance - Reported sales for the third quarter were $4.2 billion, an increase of 4%, with organic sales growth of 3% driven by a value price increase from 2% to 3% and 1% volume growth[3]. - Reported diluted EPS was $2.05, a decrease of 21%, while adjusted diluted EPS was $2.07, reflecting a 13% increase compared to the previous year[3]. - The 2025 adjusted diluted EPS outlook has been refined to a range of $7.48 to $7.58, representing a growth of 12% to 14% compared to 2024[3][22]. - Ecolab reported net sales of $4.165 billion for Q3 2025, a 4% increase compared to $3.999 billion in Q3 2024[41]. - The company's operating income decreased by 27% to $760.2 million in Q3 2025 from $1.044 billion in Q3 2024[41]. - Net income attributable to Ecolab was $585 million in Q3 2025, down 21% from $736.5 million in Q3 2024[41]. - Diluted earnings per share fell to $2.05 in Q3 2025, a 21% decrease from $2.58 in Q3 2024[41]. - Ecolab's total special (gains) and charges for Q3 2025 amounted to $26.2 million, compared to a negative $332.6 million in Q3 2024[41]. - The company experienced a 48% reduction in provision for income taxes, totaling $128 million in Q3 2025 compared to $246.5 million in Q3 2024[41]. - Adjusted diluted earnings per share for Q3 2025 were reported at $2.07, compared to $1.83 in Q3 2024, reflecting a growth of 13.1%[58]. Segment Performance - The Global Water segment reported sales of $1.95 billion, a 3% increase, with organic sales growth of 2% driven by strong Food & Beverage sales[13]. - The Global Institutional & Specialty segment achieved organic sales growth of 4%, with reported sales of $1.54 billion, reflecting a 1% increase[15]. - The Global Pest Elimination segment reported sales of $322.6 million, a 7% increase, with organic growth of 6% driven by gains in food & beverage and healthcare[16]. - Operating income for the Global Life Sciences segment increased by 18% to $28.1 million in Q3 2025, up from $23.9 million in Q3 2024[44]. - Global Institutional & Specialty segment's net sales decreased by 1% to $1,544.8 million in Q3 2025 from $1,525.7 million in Q3 2024[44]. - Global Water segment reported net sales of $1,953.5 million for Q3 2025, a decrease of 1.2% from Q3 2024[56]. - The Global Pest Elimination segment achieved net sales of $322.6 million in Q3 2025, a 6.9% increase compared to $301.7 million in Q3 2024[56]. - Operating income for the Global Institutional & Specialty segment was $365.0 million in Q3 2025, up from $327.6 million in Q3 2024, representing an increase of 11.4%[56]. - The Global Life Sciences segment reported operating income of $28.1 million in Q3 2025, up from $23.9 million in Q3 2024, an increase of 17.6%[56]. Cash Flow and Expenses - Ecolab's free cash flow is defined as net cash provided by operating activities less cash outlays for capital expenditures, indicating the company's ability to generate cash[35][36]. - The cost of sales for the company was $2.299 billion in Q3 2025, a 2% increase from $2.261 billion in Q3 2024[41]. - Ecolab's service and lease sales increased to $902.4 million in Q3 2025, up from $842.5 million in Q3 2024, reflecting a growth of 7%[41]. - The total operating income at fixed currency rates for Q3 2025 was $722.8 million, down from $1,019.2 million in Q3 2024, indicating a decline of 29.1%[56]. Company Overview - The company operates in over 170 countries and has annual sales of approximately $16 billion, employing around 48,000 associates[25]. - Total assets as of September 30, 2025, were $23,897.6 million, an increase from $22,101.6 million as of September 30, 2024[49]. - Total liabilities as of September 30, 2025, were $14,143.7 million, an increase from $13,526.1 million as of September 30, 2024[49]. Market Conditions and Outlook - Ecolab's confidence in its earnings growth trajectory remains strong despite unpredictable global operating conditions[21]. - The company expects fourth quarter 2025 adjusted diluted EPS in the range of $2.02 to $2.12, representing a growth of 12% to 17% compared to the previous year[23]. - The company experienced a currency impact of $173.1 million on net sales in Q3 2025, compared to $111.8 million in Q3 2024[56]. - Special charges for Q3 2025 amounted to $24.6 million, while in Q3 2024, the company recorded special charges of $(331.7) million[56].

Key Takeaways ECL's Global Water segment saw growth from Food & Beverage and High-Tech water innovations.Ecolab gained in Pest Elimination through North America deals and strength in key end markets.ECL's third-quarter 2025 EPS is expected to grow 12.6% year over year on projected revenues of $4.12 billion.Ecolab, Inc. (ECL) is scheduled to report third-quarter 2025 results on Oct. 28, before the opening bell.In the last reported quarter, the company’s adjusted earnings per share (EPS) of $1.89 missed the Z ...

Group 1 - The article discusses the positive outlook for Ecolab (NYSE: ECL) shares, highlighting stronger earnings growth momentum and guidance for continued performance [1] - The investing group "Value In Corporate Events" focuses on identifying opportunities in major corporate events such as IPOs, mergers & acquisitions, and earnings reports [1] - The service provides coverage of 10 major events per month, aiming to find the best investment opportunities for its members [1]

Core Insights - Ecolab Inc. has launched its 3D TRASAR Technology for Direct-to-Chip Liquid Cooling in Southeast Asia, specifically in Singapore, marking a significant innovation for high-performance computing and data center environments [1][4] Industry Context - The Asia Pacific region is the fastest-growing data center hub, accounting for over 40% of new global capacity, with demand expected to double by 2030 due to AI, cloud computing, and high-performance computing [5] - In Singapore, data centers currently account for 7% of national electricity use, with cooling systems consuming up to 40% of this share, highlighting the need for efficiency and sustainability [8] Company Positioning - Ecolab's new technology provides real-time monitoring of coolant health indicators, enhancing operational efficiency and environmental stewardship [2][4] - The launch aligns with Singapore's Green Plan 2030, supporting sustainability goals by improving Water Use Efficiency and Power Usage Effectiveness [9][10] - Ecolab's entry into the direct-to-chip cooling segment addresses the pressing challenges of power and water consumption in the expanding data center market [8][12] Strategic Initiatives - Ecolab is also investing in talent development through partnerships with local educational institutions, ensuring a skilled workforce for future data center operations [11] - The introduction of this technology is a strategic move to capture value in a rapidly growing digital infrastructure market, reinforcing Ecolab's long-standing presence in Southeast Asia [12][13]

Company Overview - Ecolab Inc. has a market cap of $79.8 billion and is a global leader in water, hygiene, and infection prevention solutions and services, operating through four segments: Global Industrial, Global Institutional & Specialty, Global Healthcare & Life Sciences, and Global Pest Elimination [1] Earnings Expectations - Ecolab is expected to announce its fiscal Q3 2025 earnings results on October 28, with analysts predicting an adjusted EPS of $2.07, a 13.1% increase from $1.83 in the same quarter last year [2] - For fiscal 2025, analysts forecast an adjusted EPS of $7.53, representing a 13.2% increase from $6.65 in fiscal 2024, and an anticipated growth to $8.53 in fiscal 2026 [3] Stock Performance - Over the past 52 weeks, Ecolab shares have risen 11.4%, underperforming the S&P 500 Index's 17.4% return but outperforming the Materials Select Sector SPDR Fund's 4.8% decline [4] Recent Financial Results - Ecolab reported Q2 2025 revenue of $4.03 billion, which was better than expected, but shares fell 3.9% due to an adjusted EPS of $1.89 that narrowly missed Wall Street's forecast. The company also noted reduced demand in its Global Institutional & Specialty segment, with sales down 2.4% to $1.5 billion year-over-year [5] Analyst Ratings - The consensus view on Ecolab stock is cautiously optimistic, with a "Moderate Buy" rating from 27 analysts. The breakdown includes 12 "Strong Buy," 2 "Moderate Buy," and 13 "Hold" recommendations. The average analyst price target is $289.40, indicating a potential upside of 2.9% from current levels [6]

Group 1 - Membrion has completed a $20 million Series B1 funding round, with participation from notable investors including Pangaea Ventures, PureTerra Ventures, Ecolab Inc., and W. L. Gore & Associates [2][3] - The funding round also includes contributions from The Lewis Family Office and existing investors such as Safar Partners, Lam Research, Indico Ventures, and Giantleap Capital [2] - Membrion's technology focuses on adaptive water infrastructure, enabling industrial facilities to recover clean water and critical minerals from challenging waste streams, thus ensuring operational reliability amid regulatory and climate changes [3]